Correction: Characterization of transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis (PLoS One (2018) 13:4 (e0196433) DOI: 10.1371/journal.pone.0196433)

1Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Dr. Javier Fidalgo-Lopez, Dr. Guy Fournet, and Dr. Benoît Joseph are not included in the author byline. The contributions of these authors are as follows: Design and synthesis of BJJF078. Please view the correct author byline, affiliations, and citation here: Navina L. Chrobok 1 , John G. J. M. Bol 1 , Cornelis A. Jongenelen 1 , John J. P. Brevé 1 , Said El Alaoui 2 , Javier Fidalgo-Lopez 2 , 3, Guy Fournet 3 , Benoît Joseph 3 , Micha M. M. Wilhelmus 1 , Benjamin Drukarch 1 , Anne-Marie van Dam 1 These authors contributed equally to this work. 1 Department of Anatomy and Neurosciences, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands, 2 Covalab, Villeurbanne, France, 3 Institut de Chimie et Biochimie Moléculaires et Supramoléculaires, Université Claude Bernard—Lyon 1, Villeurbanne, France Chrobok NL, Bol JGJM, Jongenelen CA, Brevé JJP, El Alaoui S, Fidalgo-Lopez J, et al. (2018) Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis. PLoS ONE 13(4): e0196433. https://doi.org/10.1371/journal.pone.0196433 There is an error in the fifth sentence of the Materials and methods section under the subheading “Inhibition of recombinant Transglutaminase activity”. The correct sentence is: The two lyophilized TG2 inhibitors (see Fig 1 for chemical structure) BJJF078 (3,4-Dimethoxy-N-(5-[4-(acryloylamino)piperidine-1-sulfonyl]-naphthalen-1-yl)-benzamide, see S1 Appendix, synthetized and provided by Covalab, Villeurbanne, France and Institut de Chimie et Biochimie Moléculaires et Supramoléculaires, Villeurbanne, France) and ERW1041E (2-[(3-Bromo-4,5-dihydro-isoxazol-5-ylmethyl)-carbamoyl]-pyrrolidine-1—carboxylic acid quinolin-3-ylmethyl ester, kindly provided by Prof C. Khosla, Stanford University, USA) [18, 22, 23] were dissolved in DMSO (stock solution: 54 mM) and stored at -80C. (Figure Presented).

Cite

CITATION STYLE

APA

Chrobok, N. L., Bol, J. G. J. M., Jongenelen, C. A., Brevé, J. J. P., El Alaoui, S., Fidalgo-Lopez, J., … Van Dam, A. M. (2018, December 1). Correction: Characterization of transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis (PLoS One (2018) 13:4 (e0196433) DOI: 10.1371/journal.pone.0196433). PLoS ONE. Public Library of Science. https://doi.org/10.1371/journal.pone.0209522

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free